PT1150662E - Laminados contendo um principio activo para sistemas transdermicos - Google Patents

Laminados contendo um principio activo para sistemas transdermicos

Info

Publication number
PT1150662E
PT1150662E PT00907516T PT00907516T PT1150662E PT 1150662 E PT1150662 E PT 1150662E PT 00907516 T PT00907516 T PT 00907516T PT 00907516 T PT00907516 T PT 00907516T PT 1150662 E PT1150662 E PT 1150662E
Authority
PT
Portugal
Prior art keywords
active principle
sex hormone
laminates containing
percent
transdermic
Prior art date
Application number
PT00907516T
Other languages
English (en)
Inventor
Detlef Grawe
Peter Hosel
Wilfried Fischer
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of PT1150662E publication Critical patent/PT1150662E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
PT00907516T 1999-02-10 2000-02-08 Laminados contendo um principio activo para sistemas transdermicos PT1150662E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906152A DE19906152B4 (de) 1999-02-10 1999-02-10 Wirkstoffhaltige Laminate für Transdermalsysteme

Publications (1)

Publication Number Publication Date
PT1150662E true PT1150662E (pt) 2004-02-27

Family

ID=7897479

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907516T PT1150662E (pt) 1999-02-10 2000-02-08 Laminados contendo um principio activo para sistemas transdermicos

Country Status (11)

Country Link
US (1) US6902741B1 (pt)
EP (1) EP1150662B1 (pt)
JP (1) JP4132679B2 (pt)
AT (1) ATE249818T1 (pt)
AU (1) AU2908000A (pt)
CA (1) CA2372710C (pt)
DE (2) DE19906152B4 (pt)
DK (1) DK1150662T3 (pt)
ES (1) ES2207488T3 (pt)
PT (1) PT1150662E (pt)
WO (1) WO2000047191A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2742102A (en) * 2000-12-14 2002-06-24 Ortho Mcneil Pharm Inc Steroid hormone products and methods for preparing them
JP5160018B2 (ja) 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
PT1594483E (pt) 2003-02-21 2006-12-29 Schering Ag Penso transdérmico estável aos uv
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
DE10348046A1 (de) * 2003-10-16 2005-05-19 Beiersdorf Ag Verfahren zur Herstellung von Matrizes für transdermale oder topicale Wirkstoffsysteme
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
NZ548091A (en) * 2003-12-12 2009-12-24 Bayer Schering Pharma Ag Transdermal delivery system of hormones without penetration enhancers
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
DE102004016779A1 (de) * 2004-04-01 2006-01-19 Schering Ag Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
EP1744714A4 (en) * 2004-04-07 2009-08-26 Dermatrends Inc TRANSDERMAL DISTRIBUTION SYSTEM FOR USE WITH BASIC PERMEATION IMPROVERS
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
CN102091079B (zh) * 2005-06-03 2014-03-12 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
BRPI0720945A2 (pt) 2007-01-11 2012-12-25 Acrux Dds Pty Ltd instrumento espalhador
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2111857A1 (de) * 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
JP5695562B2 (ja) * 2008-05-30 2015-04-08 マイラン・インコーポレーテッド 安定化された経皮薬物送達システム
JP2012504609A (ja) 2008-10-06 2012-02-23 マイラン・テクノロジーズ，インコーポレイテッド アモルファスロチゴチン経皮システム
SI2613772T1 (sl) 2010-09-06 2017-03-31 Bayer Intellectual Property Gmbh Transdermalni obliži z nizkim odmerkom z visoko stopnjo sproščanja zdravila
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
EP3395336A1 (en) * 2017-04-28 2018-10-31 Nitto Denko Corporation Transdermal absorption preparation
CA3213072A1 (en) * 2021-03-30 2022-10-06 David P. Kanios Transdermal systems having low dose estrogen and methods of making and use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
JPS6193112A (ja) * 1984-06-15 1986-05-12 Sekisui Chem Co Ltd 貼付剤
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
IT1250421B (it) 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4334553C2 (de) 1993-10-11 1998-05-20 Synopharm Gmbh Pharmazeutische Flüssiges pharmazeutisches System zur perkutanen Applikation
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447715C2 (de) 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
JPH10306023A (ja) * 1997-05-06 1998-11-17 Sekisui Chem Co Ltd 経皮吸収製剤及びその製造方法
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition

Also Published As

Publication number Publication date
WO2000047191A1 (de) 2000-08-17
JP2002536403A (ja) 2002-10-29
EP1150662B1 (de) 2003-09-17
CA2372710C (en) 2006-04-11
ATE249818T1 (de) 2003-10-15
DE19906152B4 (de) 2005-02-10
ES2207488T3 (es) 2004-06-01
US6902741B1 (en) 2005-06-07
DK1150662T3 (da) 2004-01-26
CA2372710A1 (en) 2000-08-17
EP1150662A1 (de) 2001-11-07
AU2908000A (en) 2000-08-29
JP4132679B2 (ja) 2008-08-13
DE19906152A1 (de) 2000-08-17
DE50003721D1 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
PT1150662E (pt) Laminados contendo um principio activo para sistemas transdermicos
BRPI0507683A8 (pt) dose unitária de formulação farmacêutica com liberação controlada, seu processo de preparação e uso de um copolímero de poli(acrilato de etila, metacrilato de metila) neutro
AR038575A1 (es) Formulacion oftalmica con nueva composicion de goma
CO5570662A2 (es) Formulacion farmaceutica que contiene 3-(3-dimetilamino-1- etil-2-metil-propil) fenol y proporciona una liberacion retardada del ingrediente activo
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
FI960556A0 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
DK1691851T3 (da) Sårplaster og fremgangsmåder
AR097045A2 (es) Sistema terapéutico transdérmico
PT80865B (pt) Dispositivo de libertacao de um principio activo
CA2193129A1 (en) Transdermal drug delivery system
ES2159591T3 (es) Composicion de liberacion controlada.
DK1418951T3 (da) Transdermalt teraeutisk system (TTS) med fentanyl som aktiv bestanddel
HRP20050828B1 (hr) Uv-stabilni transdermalni flaster
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
BR0007360A (pt) Composição de liberação controlada
RU2001133344A (ru) Трансдермальная терапевтическая система (ТТС), содержащая толтеродин
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
ATE251453T1 (de) Pflaster für die lokale und transdermale verabreichung von wirkstoffen mit anionischen oder elektronen-anziehenden gruppen
WO2002030402A3 (en) Film for active ingredients dermal and transdermal administration
BR0012735A (pt) Preparação solida, e, processo para produzir preparações
NL192780B (nl) Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof.
FI955524A0 (fi) Kiinteinä liuoksina olevia valmisteita
BRPI0405662A (pt) Emplastros contendo turobuterol
WO2006117139A3 (de) Festes transdermales therapeutisches system mit uv-absorber